Table 3 Population components of patients attending publicly funded primary health centers in 2017 with all five MetS component data available
From: Prevalence of metabolic syndrome in primary health settings in Qatar: a cross sectional study
Population Demographics | Prevalence of MetS (Total population = 127,941) | |
|---|---|---|
N | % | |
Age (years) | ||
18–29 | 2349 | 14.9 |
30–39 | 9362 | 32.5 |
40–49 | 15,906 | 50.3 |
50–59 | 18,592 | 64.2 |
60 + | 16,287 | 71.5 |
Gender | ||
Women | 30,145 | 42.5 |
Men | 32,351 | 56.7 |
Nationality | ||
Southern Asia | 19,310 | 60 |
Northern Africa | 10,853 | 50.7 |
Western Asia (excluding Qatar) | 9090 | 46.8 |
Australasia | 41 | 43.2 |
Qatar | 19,707 | 43 |
Northern America | 333 | 42.3 |
South-eastern Asia | 2204 | 40.5 |
Northern Europe | 210 | 38.3 |
Sub-Saharan Africa | 600 | 36.1 |
Latin America and the Caribbean | 30 | 35.3 |
Eastern-Central Asia | 20 | 33.9 |
Eastern Europe | 37 | 29.4 |
Western Europe | 34 | 29.3 |
Southern Europe | 26 | 20.6 |